Merck & Co Inc
NYSE: MRK
$100.49
+$0.40 (+0.4%)
Real Time Data Delayed 15 Min.
MRK Articles
According to Reuters, Citigroup (C) will take $49 billion of SIVs onto its balance sheet. Reuters writes that Nissan and Chrysler may begin to partner in building new cars Reuters reports that Acer...
Published:
Merck (MRK) is not going to do as well as Wall St. had hoped next year. It guided to $3.28 to $3.38 earnings per share. A Reuters poll puts the number at $3.27. Merck shares have been near a 52-week...
Published:
Allscripts (MDRX) traded down 25% after missing earnings estimates and after lower guidance for 2007 and 2008. American Tower (AMT) replacing Alltel (AT) in S&P. ARM Holdings plc (ARMHY) trading...
Published:
It has been a bloody and bitter fight. Merck’s (MRK) pain killer Vioxx has been alleged to cause heart problems and worse. The drug hit the market in 1999 and was pulled in 2004. At that point the...
Published:
The markets haven’t fallen apart after yesterday’s 360 point dive on the DJIA, but we are still trading a tad lower today. Now that Cisco Systems is showing you can’t just automatically hide...
Published:
GTx, Inc. (NASDAQ: GTXI) is seeing shares trade sharply higher on a collaboration pact with Merck (NYSE: MRK). The biotech and drug giant pact is for research and development and a strategic...
Published:
With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks listing lower after the Exxon miss, we wanted to show a brief comparison of...
Published:
Last Updated:
Merck (MRK) announced third-quarter 2007 earnings per share of $0.75, excluding restructuring charges, and third-quarter reported EPS of $0.70. Worldwide sales were $6.1 billion for the quarter, an...
Published:
Astoday is the 20th anniversary of the 1987 stock market crash, 24/7 WallSt. wanted to go back in time to review how the individual DJIAcomponents held up around the time and how they have run to...
Published:
Last Updated:
Merck’s (MRK) has won almost every liability case it has faced over side-effects of its pain killer Vioxx. It has gotten to the point where plaintiff’s attorneys don’t want to risk their time...
Published:
According to Reuters, Nokia (NOK) said the the ITC has begin an investigation into Qualcomm (QCOM) trade practives and patent infringements. Reuters writes that Boeing (BA) is estimating that China...
Published:
We are frequently asked about how certain basket picks perform compared to the overall market. It has been years since anyone has claimed their stocks should gain regardless of the market because...
Published:
If you ever heard the old saying "Be careful what you wish for, you may get it!" it sure seems like we are there. It also makes you wonder if it is time to go back into Defensive Stocks. The...
Published:
Last Updated:
Patients who swtich from Pfizer’s (PFE) monster selling drug cholesterol pill Lipitor to Merck’s (MRK) Zocor, now available in generic form are more likely to have a heart attack or die....
Published:
Business Week has run a brief feature article on Ariad Pharmaceuticals (NASDAQ:ARIA) in its "Inside Wall Street" magazine section and noted that the company’s partner Merck (NYSE:MRK), has "deep...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.